Biopharm Business - BioPharm International


Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

New Gene Patent Rules

August 1, 2013

The US Supreme Court's Myriad decision satisfied both patient groups and patent holders

Fourth-generation Biologics to Drive $120 Billion Market

July 11, 2013

Fourth-generation biologics, with improved delivery and pharmacokinetics, will continue to drive an overall biologics industry that is already worth over $120 billion.

Financing Innovation

April 1, 2013

Early-stage companies are finding alternatives to venture capital.

Benchmarking: Don't Just Run the Numbers, Understand the Process

April 1, 2013

Benchmarking can be a useful tool to improve manufacturing practices.

Aggregation of Monoclonal Antibody Products: Formation and Removal

March 1, 2013

Aggregate formation is influenced by multiple aspects of the bioproduction process but can be mitigated by good process design and control.

Therapeutic Antibodies in Review

February 1, 2013

Innovative products and a range of indications drive the therapeutic antibody market.

Accelerating Change Marks 2012 for Life Sciences

January 1, 2013

A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.

Biologics: What Does the Future Hold?

January 1, 2013

Neil Lewis, chief technology officer at Malvern Instruments, talks about the challenges associated with biologics.

Navigating Emerging Markets

December 1, 2012

An introduction to a new series on manufacturing within global markets.



Click here